Nantes University Hospital
π«π·France
- Country
- π«π·France
- Ownership
- Private
- Established
- 1503-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- https://www.chu-nantes.fr
Unruptured Cerebral Aneurysm: Prediction of Evolution
Recruiting
- Conditions
- First Posted Date
- 2020-10-08
- Last Posted Date
- 2024-03-19
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT04578808
- Locations
- π«π·
Limoges University Hospital, Limoges, Haute-Vienne, France
π«π·Nancy University Hospital, Nancy, Meurthe-et-Moselle, France
π«π·Clairval's Hospital, Marseille, Bouches-du-RhΓ΄ne, France
Validation of a Biomathematical Model to Help Identify the Parameters of Flexible Insulin Therapy
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-10-01
- Last Posted Date
- 2022-10-21
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 37
- Registration Number
- NCT04572009
- Locations
- π«π·
CHU de Nantes, Nantes, France
Predictive Signature of Benralizumab Response
Phase 4
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-09-25
- Last Posted Date
- 2024-04-26
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 220
- Registration Number
- NCT04565483
- Locations
- π«π·
CHRU Brest, Brest, France
π«π·CHU Lille, Lille, France
π«π·CHU Rouen, Rouen, France
Relevance of [68Ga]Ga -PentixaFor-PET for Initial Staging and Therapeutic Evaluation of Multiple Myeloma
- First Posted Date
- 2020-09-23
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 45
- Registration Number
- NCT04561492
- Locations
- π«π·
CHU Bordeaux, Bordeaux, France
π«π·CHU Lille, Lille, France
π«π·HCL, Lyon, France
Cerebral Autoregulation in Pediatric ECMO (ECMOX 2)
Completed
- Conditions
- First Posted Date
- 2020-09-14
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 132
- Registration Number
- NCT04548739
- Locations
- π«π·
AP-HP Necker Hospital, Paris, France
π«π·AP-HP Trousseau Hospital, Paris, France
π«π·CHU de Nantes, Nantes, France
Monocentric Phase 1 Study With Escalation of Doses of Tocilizumab in Combination With Chemotherapy (Idarubicin and Cytarabine) in Patients With Acute Myeloblastic Leukemia (AML)
Phase 1
Completed
- Conditions
- First Posted Date
- 2020-09-14
- Last Posted Date
- 2023-04-28
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT04547062
- Locations
- π«π·
CHU of Nantes, Nantes, France
SYTHROM Cohort, Myeloproliferative Neoplasia With Normal CBC and Thrombotic Complications
- First Posted Date
- 2020-09-07
- Last Posted Date
- 2021-09-09
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT04539678
- Locations
- π«π·
Nantes University Hospital, Nantes, Loire-Atlantique, France
Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux Levels
- First Posted Date
- 2020-09-04
- Last Posted Date
- 2024-05-07
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 2100
- Registration Number
- NCT04539301
- Locations
- π«π·
Nantes University Hospital, Nantes, Loire-Atlantique, France
MICRA - Pilot Study
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-09-03
- Last Posted Date
- 2021-10-06
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT04536883
- Locations
- π«π·
CHU Nantes, Nantes, France
Efficacy of a Multi-faceted Intervention Combining an Educational Outreach Visit to General Practitioners and Patient Education Material to Deprescribe Proton Pump Inhibitors (PPI): a Population-based, Pragmatic, Cluster-randomized Controlled Trial
- First Posted Date
- 2020-08-14
- Last Posted Date
- 2024-04-22
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 25000
- Registration Number
- NCT04513834
- Locations
- π«π·
University Hospital, Nantes, France
Β© Copyright 2024. All Rights Reserved by MedPath